Acadia Healthcare (NASDAQ:ACHC) Sets New 12-Month Low - Time to Sell?
Acadia Healthcare (NASDAQ:ACHC) reached a new 52-week low of $25.12 during trading, closing at $25.15. Analysts have downgraded the stock from "hold" to "sell" and adjusted target prices downwards, with an average rating of "Moderate Buy" and a target price of $50.39. The company has a market cap of $2.30 billion and a P/E ratio of 8.11. Institutional investors have been active, with several increasing their stakes in the company. Acadia Healthcare provides behavioral healthcare services across the U.S. and Puerto Rico.
Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Get Free Report) reached a new 52-week low during mid-day trading on Tuesday . The stock traded as low as $25.12 and last traded at $25.15, with a volume of 756654 shares traded. The stock had previously closed at $26.39.
Get Acadia Healthcare alerts:
Analyst Ratings Changes
- Neurogene Stock Plummets 44%: Is All Hope Lost for This Biotech?"
Several research analysts have commented on ACHC shares. StockNews.com downgraded Acadia Healthcare from a "hold" rating to a "sell" rating in a research note on Monday, January 6th. Bank of America cut their target price on Acadia Healthcare from $50.00 to $44.50 and set a "buy" rating on the stock in a research report on Friday, February 28th. TD Cowen lowered their target price on Acadia Healthcare from $70.00 to $66.00 and set a "buy" rating for the company in a report on Tuesday, January 7th. Mizuho dropped their price objective on shares of Acadia Healthcare from $48.00 to $37.00 and set a "neutral" rating on the stock in a report on Tuesday, March 25th. Finally, KeyCorp decreased their target price on Acadia Healthcare from $70.00 to $65.00 and set an "overweight" rating for the company in a research report on Monday, March 3rd. One research analyst has rated the stock with a sell rating, three have issued a hold rating and six have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $50.39.
Check Out Our Latest Stock Report on ACHC
Acadia Healthcare Trading Down 6.3 %
The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07. The company has a market capitalization of $2.30 billion, a P/E ratio of 8.11, a price-to-earnings-growth ratio of 1.46 and a beta of 1.13. The firm has a fifty day moving average price of $32.85 and a 200-day moving average price of $40.69.
Institutional Investors Weigh In On Acadia Healthcare
A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Treasurer of the State of North Carolina grew its stake in Acadia Healthcare by 0.6% during the fourth quarter. Treasurer of the State of North Carolina now owns 40,005 shares of the company's stock valued at $1,586,000 after acquiring an additional 250 shares in the last quarter. Nisa Investment Advisors LLC grew its position in shares of Acadia Healthcare by 40.7% during the 4th quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company's stock valued at $41,000 after purchasing an additional 301 shares in the last quarter. Coldstream Capital Management Inc. increased its holdings in shares of Acadia Healthcare by 4.9% in the fourth quarter. Coldstream Capital Management Inc. now owns 6,470 shares of the company's stock worth $257,000 after purchasing an additional 303 shares during the period. Covestor Ltd boosted its stake in Acadia Healthcare by 27.2% during the fourth quarter. Covestor Ltd now owns 1,450 shares of the company's stock valued at $58,000 after buying an additional 310 shares during the period. Finally, Pacer Advisors Inc. grew its position in Acadia Healthcare by 2.4% during the fourth quarter. Pacer Advisors Inc. now owns 13,847 shares of the company's stock worth $549,000 after buying an additional 325 shares in the last quarter.
About Acadia Healthcare
(Get Free Report)Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Further Reading
- Five stocks we like better than Acadia Healthcare
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Beware of BigBear.ai: Insiders Are Selling—Should You?
- How to Calculate Retirement Income: MarketBeat’s Calculator
- CrowdStrike Stock is a Buy as Cyberthreat Environment Expands
- What Are Trending Stocks? Trending Stocks Explained
- Congress! Who Traded What During the Tariff-Induced Meltdown
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Should You Invest $1,000 in Acadia Healthcare Right Now?
Before you consider Acadia Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.
While Acadia Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
